Axsome Therapeutics (NASDAQ:AXSM) Receives Buy Rating from Needham & Company LLC
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reiterated by Needham & Company LLC in a research note issued on Monday,Benzinga reports. They presently have a $133.00 price target on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 0.61% from the stock’s previous close. Several […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reiterated by Needham & Company LLC in a research note issued on Monday,Benzinga reports. They presently have a $133.00 price target on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 0.61% from the stock’s previous close. Several […]
